Logo image of MNK

MALLINCKRODT PLC (MNK) Stock Overview

USA - NYSEARCA:MNK - IE000O3L0NQ3 - Common Stock

0.3402 USD
-0.06 (-14.97%)
Last: 8/25/2023, 8:14:49 PM
0.3505 USD
+0.01 (+3.03%)
Pre-Market: 8/28/2023, 8:03:16 AM

MNK Key Statistics, Chart & Performance

Key Statistics
52 Week High18.1
52 Week Low0.3
Market Cap4.48M
Shares13.17M
Float11.08M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO07-15 2013-07-15
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


MNK short term performance overview.The bars show the price performance of MNK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

MNK long term performance overview.The bars show the price performance of MNK in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of MNK is 0.3402 USD. In the past month the price decreased by -68.5%.

MALLINCKRODT PLC / MNK Daily stock chart

MNK Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 52 794.90B
JNJ JOHNSON & JOHNSON 18.86 454.31B
NVO NOVO-NORDISK A/S-SPONS ADR 15.17 264.96B
AZN ASTRAZENECA PLC-SPONS ADR 19.21 264.50B
NVS NOVARTIS AG-SPONSORED ADR 14.96 256.29B
MRK MERCK & CO. INC. 11.58 222.78B
PFE PFIZER INC 8.07 155.61B
SNY SANOFI-ADR 11.41 124.05B
BMY BRISTOL-MYERS SQUIBB CO 6.75 92.51B
GSK GSK PLC-SPON ADR 9.59 87.24B
ZTS ZOETIS INC 23.54 64.89B
TAK TAKEDA PHARMACEUTIC-SP ADR 50.34 46.11B

About MNK

Company Profile

MNK logo image Mallinckrodt Plc engages in the development, manufacture, market, adn distribution of both branded and generic specialty pharmaceutical products and medical imaging agents. The firm operates in two reportable segments: Specialty Brands and Specialty Generics. The Specialty Brands includes specialty pharmaceutical brands. The Specialty Generics includes niche specialty generic drugs and active pharmaceutical ingredients. Its Specialty Generics segment is focused on providing its customers with specialty generic drugs and active pharmaceutical ingredients (APIs). The firm focuses on various therapeutic areas, such as autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics, cultured skin substitutes and gastrointestinal products. Its product portfolio includes Acthar Gel, INOmax, Therakos photopheresis, StrataGraft, Terlivaz, and Amitiza.

Company Info

MALLINCKRODT PLC

College Business & Technology Park, Cruiserath,, Blanchardstown

DUBLIN D15 IE

CEO: Mark C. Trudeau

Employees: 2700

MNK Company Website

MALLINCKRODT PLC / MNK FAQ

What is the stock price of MALLINCKRODT PLC today?

The current stock price of MNK is 0.3402 USD. The price decreased by -14.97% in the last trading session.


What is the ticker symbol for MALLINCKRODT PLC stock?

The exchange symbol of MALLINCKRODT PLC is MNK and it is listed on the NYSE Arca exchange.


On which exchange is MNK stock listed?

MNK stock is listed on the NYSE Arca exchange.


What is MALLINCKRODT PLC worth?

MALLINCKRODT PLC (MNK) has a market capitalization of 4.48M USD. This makes MNK a Nano Cap stock.


How many employees does MALLINCKRODT PLC have?

MALLINCKRODT PLC (MNK) currently has 2700 employees.


What are the support and resistance levels for MALLINCKRODT PLC (MNK) stock?

MALLINCKRODT PLC (MNK) has a resistance level at 0.62. Check the full technical report for a detailed analysis of MNK support and resistance levels.


Should I buy MALLINCKRODT PLC (MNK) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MALLINCKRODT PLC (MNK) stock pay dividends?

MNK does not pay a dividend.


MNK Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

MNK Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

MNK Forecast & Estimates


Analysts
Analysts42.4
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

MNK Ownership

Ownership
Inst Owners0%
Ins Owners5.74%
Short Float %N/A
Short RatioN/A